Medicare expands who can approve diabetic shoe coverage
H.R. 1616 — Promoting Access to Diabetic Shoes Act · Filed by Darin LaHood (R-IL) · 63 cosponsors · Introduced Feb 26, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill allows nurse practitioners and physician assistants to sign off on the medical documentation required for Medicare to cover therapeutic shoes for diabetic patients. Currently, only physicians can provide this certification; the bill expands the list of qualified providers to include nurse practitioners and physician assistants, removing a bureaucratic bottleneck that may delay or prevent diabetic patients from accessing medically necessary footwear.
Why we flagged it
The bill's sole function is to broaden the set of licensed healthcare providers authorized to document medical necessity for a specific Medicare benefit. It is a straightforward regulatory clarification that removes a provider-type restriction.
What the text implies
- Reduces administrative delays for diabetic patients seeking shoe coverage, potentially lowering preventable complications (ulcers, amputations) and associated downstream Medicare costs.
- May increase volume of shoe-coverage claims if nurse practitioners and physician assistants are more accessible than physicians in rural or underserved areas.
- Implicitly recognizes nurse practitioners and physician assistants as clinically competent to assess diabetic foot pathology — a scope-of-practice precedent that may inform future Medicare coverage decisions.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Diabetic patients benefit from faster, less restrictive access to medically necessary therapeutic shoes, which reduce foot complications and ulceration risk. The expansion of authorized providers removes an artificial bottleneck without compromising clinical judgment — nurse practitioners and physician assistants are licensed, regulated providers trained in diabetes management and foot care assessment.
Who stands to gain
- orthopedic shoe manufacturers and suppliers (increased volume of covered claims)
- nurse practitioners and physician assistants (expanded billable services)
Named in the bill
Centers for Medicare & Medicaid Services (CMS), nurse practitioners, physician assistants, physicians, Medicare, Social Security Act § 1861(s)(12)
Where it stands
63 cosponsors: 48 Democrats, 15 Republicans.
- Feb 26, 2025 — Introduced · Congress.gov: “Introduced in House”
- Feb 26, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
8 lobbying clients named this bill on 12 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,913,067 in lobbying spend. A filing names 25 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 88% of bills with at least one filing.
Darin LaHood, the sponsor, reported $1,837,341 in PAC receipts in the 2026 cycle.
- American Association of Nurse Practitioners — $950,000 on 2 filings
- American Academy of Physician Associates — $320,000 on 2 filings
- American Nurses Association — $270,000 on 1 filing
- American Association of Nurse Practitioners — $130,000 on 2 filings
- American Academy of Physician Associates — $120,000 on 2 filings
Lobbying Disclosure Act filings through Jul 22, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (530 characters) on Aug 15, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 22, 2026 · page rendered 2026-10-20.
- H.R. 1616 on Congress.gov
- Actions and status history
- Cosponsors (63)
- Bill text the analysis read
- American Association of Nurse Practitioners — LDA filing, 2025 Q4
- American Academy of Physician Associates — LDA filing, 2026 Q2
- American Nurses Association — LDA filing, 2026 Q2
- Darin LaHood — FEC candidate receipts, 2026 cycle
“Medicare expands who can approve diabetic shoe coverage” QuorumCivic. https://share.quorumcivic.app/bill/119/hr1616 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.